Effect of Casein Hydrolysate on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Zhou S, Xu T, Zhang X, Luo J, An P
Published in Nutrients
Methodology
Systematic review and meta-analysis of randomized controlled trials of casein hydrolysate supplementation on blood pressure, lipids and glucose
Key Findings
Casein hydrolysate reduced systolic blood pressure by 3.20 mmHg and diastolic blood pressure by 1.50 mmHg, with no effect on total cholesterol, LDL, HDL, triglycerides or glucose.
Conclusions
Benefit of casein hydrolysate appears limited to modest blood pressure lowering; lipid and glycaemic risk factors are unchanged.
Limitations
Heterogeneous hydrolysate preparations and doses; mostly short-duration trials with surrogate endpoints.
Supplements Studied
Casein hydrolysate significantly reduced systolic blood pressure by 3.20 mmHg (-4.53 to -1.87 mmHg) and diastolic blood pressure by 1.50 mmHg (-2.31 to -0.69 mmHg).
Related Health Concerns
Study Details
Access Study
Disclosures
Funding
Not specified
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.